Orion · ISIN: FI0009014377

79,345 Orion Corporation A shares converted into B shares

ORION CORPORATIONSTOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE13 JANUARY 2025 at 9.50 EET          ...

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

This news feed is a compilation of company-relevant news from the most popular and widest-reaching newswire services. The feed is updated several times. For market-related publications, we recommend the X-Billboard, the Daily News Digest or our Premium Information Service.
Most recent update: 13.01.2025 | 07:50
13 January 2025 07:50AM
79,345 Orion Corporation A shares converted into B shares
ORION CORPORATIONSTOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE13 JANUARY 2025 at 9.50 EET          ...
© Globe Newswire
07 January 2025 07:00AM
Orion’s collaboration partner Bayer submits application in China for third indication of darolutamide
ORION CORPORATION INVESTOR NEWS 7 JANUARY 2025 at 9:00 EET...
© Globe Newswire
19 December 2024 05:00PM
Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD/MANAGEMENT/AUDITORS19 DECEMBER 2024 at 19.00 EET...
© Globe Newswire
18 December 2024 03:00PM
Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics
ORION CORPORATION PRESS RELEASE 18 DECEMBER 2024 at 17.00 EET ...
© Globe Newswire
12 December 2024 06:30PM
Penalty payment to a member of Orion’s Board of Directors for delay in notifying managers’ transaction
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE12 DECEMBER 2024 at 20.30 EET...
© Globe Newswire
27 November 2024 07:00AM
142,701 Orion Corporation A shares converted into B shares
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE27 NOVEMBER 2024 at 9.00 EET          ...
© Globe Newswire
22 November 2024 07:00AM
Orion Research Foundation grants EUR 1,109,000 for research in 2025
Orion Research Foundation grants EUR 1,109,000 for research in 2025...
© Globe Newswire
19 November 2024 04:30PM
Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies
ORION CORPORATION INVESTOR NEWS 19 NOVEMBER 2024 at 18.30 EET      ...
© Globe Newswire
01 November 2024 07:45AM
Orion Corporation: Managers’ transactions – Henrik Stenqvist
ORION CORPORATION MANAGERS’ TRANSACTIONS 1 NOVEMBER 2024 at 9.45 EET...
© Globe Newswire
29 October 2024 10:00AM
Orion Group Interim Report January–September 2024
ORION CORPORATION INTERIM REPORT 1–9/2024 29 OCTOBER 2024 at 12:00 EET...
© Globe Newswire
24 October 2024 04:50PM
Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION24 OCTOBER 2024 at 19.50 EEST...
© Globe Newswire
15 October 2024 06:00AM
Orion publishes Interim Report for January–September 2024 and holds a webcast on 29 October 2024
ORION CORPORATION PRESS RELEASE 15 OCTOBER 2024 at 9.00 EEST...
© Globe Newswire
14 October 2024 08:00AM
Orion’s collaboration partner Bayer submits application for third indication of darolutamide in the EU
ORION CORPORATION INVESTOR NEWS 14 OCTOBER 2024 at 11.00 EEST...
© Globe Newswire
30 September 2024 07:00AM
Orion’s near-term climate targets approved by the Science Based Targets initiative
ORION CORPORATIONPRESS RELEASE30 SEPTEMBER 2024 at 10.00 a.m. EEST...
© Globe Newswire
26 September 2024 08:00AM
Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster
ORION CORPORATION INVESTOR NEWS 26 SEPTEMBER 2024 at 11.00 EEST...
© Globe Newswire
25 September 2024 12:00PM
Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology
ORION CORPORATION PRESS RELEASE 25 SEPTEMBER 2024 at 15.00 EEST          ...
© Globe Newswire
20 September 2024 06:30AM
213,285 Orion Corporation A shares converted into B shares
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE20 SEPTEMBER 2024 at 9.30 EEST          ...
© Globe Newswire
16 September 2024 08:30AM
Darolutamide plus androgen deprivation therapy significantly reduced the risk of radiological progression or death by 46% compared to placebo plus ADT in patients with metastatic hormone-sensitive prostate cancer
ORION CORPORATION PRESS RELEASE 16 SEPTEMBER 2024 at 11.30 EEST...
© Globe Newswire
11 September 2024 06:30AM
Inside information: Orion upgrades full-year outlook for 2024
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION11 SEPTEMBER 2024 at 09:30 EEST...
© Globe Newswire
22 August 2024 07:30AM
Orion Corporation: Managers’ transactions – Satu Ahomäki
ORION CORPORATION MANAGERS’ TRANSACTIONS 22 AUGUST 2024 at 10.30 EEST        ...
© Globe Newswire
21 August 2024 03:45PM
Orion Corporation: Managers’ transactions – Niclas Lindstedt
ORION CORPORATION MANAGERS’ TRANSACTIONS 21 AUGUST 2024 at 18.45 EEST        ...
© Globe Newswire
20 August 2024 01:15PM
Orion Corporation: Managers’ transactions – Liisa Hurme
ORION CORPORATION MANAGERS’ TRANSACTIONS 20 AUGUST 2024 at 16.15 EEST        ...
© Globe Newswire
14 August 2024 06:30AM
44,767 Orion Corporation A shares converted into B shares
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE14 AUGUST 2024 at 9.30 EEST          ...
© Globe Newswire
08 August 2024 09:00AM
Orion Group Half-Year Financial Report January–June 2024
ORION CORPORATION HALF-YEAR FINANCIAL REPORT 1–6/2024 8 AUGUST 2024 at 12:00 EEST...
© Globe Newswire
08 August 2024 06:45AM
Orion Corporation’s financial reporting and Annual General Meeting in 2025
ORION CORPORATION STOCK EXCHANGE RELEASE – FINANCIAL CALENDAR8 AUGUST 2024 at 9.45 EEST         ...
© Globe Newswire
25 July 2024 08:00AM
Orion publishes Half-Year Financial Report for January–June 2024 and holds a webcast on 8 August 2024
ORION CORPORATION PRESS RELEASE 25 JULY 2024 at 11.00 EEST...
© Globe Newswire
01 July 2024 12:15PM
Inside information: Orion upgrades full-year outlook for 2024
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION1 JULY 2024 at 15:15 EEST...
© Globe Newswire
01 July 2024 12:15PM
Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION1 JULY 2024 at 15:15 EEST...
© Globe Newswire
06 May 2024 09:00AM
Orion Corporation: Managers’ transactions – Karen Lykke Sørensen
ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST        ...
© Globe Newswire
06 May 2024 09:00AM
Orion Corporation: Managers’ transactions – Hilpi Rautelin
ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST        ...
© Globe Newswire
06 May 2024 09:00AM
Orion Corporation: Managers’ transactions – Maziar Mike Doustdar
ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST        ...
© Globe Newswire
06 May 2024 09:00AM
Orion Corporation: Managers’ transactions – Henrik Stenqvist
ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST        ...
© Globe Newswire
06 May 2024 09:00AM
Orion Corporation: Managers’ transactions – Veli-Matti Mattila
ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST        ...
© Globe Newswire
06 May 2024 09:00AM
Orion Corporation: Managers’ transactions – Eija Ronkainen
ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST        ...
© Globe Newswire
06 May 2024 09:00AM
Orion Corporation: Managers’ transactions – Ari Lehtoranta
ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST        ...
© Globe Newswire
06 May 2024 09:00AM
Orion Corporation: Managers’ transactions – Kari Jussi Aho
ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST        ...
© Globe Newswire

The information service offers company-relevant news from leading newswire services in a compact form for a quick overview. When the detailed view is called up, further information can be accessed if required. The navigation elements in previewer mode allow you to quickly switch to the most frequently visited tool sections. From there, you can access further areas that can be used for your own research and analysis. Tip: The information platform now includes more than 50 mini-apps developed in-house.

AI First: Feel free to test the AI integration that will quickly put you on a par with financial journalists and research houses

Further information

The information presented in this section is secondary publications. The content corresponds to the source information. You can find information on the author of the news item in the detailed information of a publication. News relating to listed companies may have been created due to regulatory publication obligations, due to regular public relations work for PR or marketing reasons or by third parties against the background of investor information.

The combination of information and graphic elements contributes significantly to visual orientation and navigation through complex issues. This makes it easier to grasp, contextualize and process key content. Images, logos and other or comparable graphic and textual elements used on the information portal are used for visual navigation, are part of the original message or have illustrative purposes. All rights to these elements are held by the respective owners of the trademark or image rights. They are used without intent to infringe copyright or intellectual property rights. Image material provided via the distribution networks is treated as part of the original message and processed accordingly.

If you believe that copyright or intellectual property rights have been infringed by the presentation, please contact us immediately to clarify your concerns.